M08.271
Juvenile rheumatoid arthritis with systemic onset, right ankle and foot
Clinical Classification Guidelines
Medical Intelligence & Overview
Juvenile rheumatoid arthritis (JRA), also known as juvenile idiopathic arthritis, is a chronic autoimmune disease affecting children under the age of 16. The subtype classified under ICD-10 code M08.271 is characterized by systemic onset symptoms and specific involvement of the right ankle and foot. It causes inflammation in the joints and may affect other parts of the body. This condition can vary in severity and may lead to joint damage if not properly managed. Recognizing the symptoms early and understanding its causes can help in managing the disease effectively.
Causes & Symptoms
Clinical Causes: Autoimmune response where the immune system mistakenly attacks healthy tissues Genetic predisposition that increases susceptibility to the disease Environmental factors like infections or allergens acting as possible triggers Hormonal influences possibly playing a role in disease onset and progression
Key Symptoms: Persistent joint swelling and redness, especially in the ankle and foot High fever that lasts several days and recurs periodically Rash that appears as pink or red spots on the skin Swollen lymph nodes and inflammation in other organs Fatigue, tiredness, and general feeling of malaise Morning stiffness that lasts for an hour or more Loss of appetite and weight loss
Diagnostic & Treatment
Diagnosis Path: Diagnosis of juvenile rheumatoid arthritis with systemic onset involves a combination of clinical evaluation and diagnostic tests. A pediatric rheumatologist will review medical history, perform a physical examination, and check for signs of systemic involvement. Laboratory tests such as blood counts, inflammatory markers (ESR and CRP), and autoantibody panels help support the diagnosis. Imaging studies like X-rays and ultrasounds may be used to assess joint damage or inflammation. Since symptoms can mimic other illnesses, early and comprehensive assessment is essential for accurate diagnosis.
Treatment Protocols: Treatment aims to reduce inflammation, control symptoms, and prevent joint damage. It often includes a combination of medications and lifestyle adjustments. Common treatments include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to lessen pain and inflammation - Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, to slow disease progression - Corticosteroids to quickly control severe inflammation - Biological agents targeting specific immune system components - Physical therapy and regular exercise to maintain joint function and muscle strength - Monitoring for side effects of medications and adjusting treatment as needed In addition to medical therapy, regular follow-up with healthcare providers is crucial to monitor disease activity and adapt treatment plans accordingly. Supportive measures include pain management strategies and educational support for children and their families to cope with the condition.
Clinical Advice & FAQs
Billing Guidance
Is M08.271 a billable ICD-10 code?
Yes, M08.271 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M08.271?
Clinical documentation must specify the nature of Juvenile rheumatoid arthritis with systemic onset, right ankle and foot and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
